ID-Free AI Proteomics

The End of Data Waste: 100% Data Utilization via ID-Free AI Proteomics

ID-Free Signal Processing

Traditional proteomics discards ~75% of MS/MS spectra as uninterpretable 'noise'. TargetX analyzes 100% of the spectral landscape, training our AI directly on raw patterns to capture hidden cancer signals that others ignore. Our ID-free approach is not just library-free; it is a fundamental shift from protein identification to Total Spectral Pattern Recognition.

Revolutionizing Multi-Cancer Early Detection (MCED)

Non-invasive Liquid Biopsy

Detects cancer signals from a standard blood draw.

Multi-Cancer Screening

Simultaneously screens for the top 10 major cancers in Korean, including high-mortality types like pancreatic cancer.

National Health Application

Designed for high sensitivity and cost-effectiveness to facilitate adoption into national cancer screening.